Completed OBSERVATIONAL NCT01192919

Tumour Registry Lung Cancer (TLK)

Clinical Registry Describing Treatment Reality and Therapy Modalities of Patients With Lung Cancer (NSCLC, SCLC and Neuroendocrine Tumors) Requiring Therapy.

Sponsor: iOMEDICO AG

Conditions Lung Cancer

Updated 8 times since 2017 Last updated: Feb 27, 2020 Started: Jan 31, 2010 Primary completion: Jul 31, 2016 Completion: Jul 31, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01192919, this observational or N/A phase trial focuses on Lung Cancer and remains completed. Sponsored by iOMEDICO AG, it has been updated 8 times since 2010, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Apr 2020 — Jan 2021 [monthly]

Completed
Jan 2019 — Apr 2020 [monthly]

Completed

▶ Show 3 earlier versions

Jun 2018 — Jan 2019 [monthly]

Completed
Apr 2018 — Jun 2018 [monthly]

Completed

Phase: NA → None
Jan 2017 — Apr 2018 [monthly]

Completed NA

First recorded

Jan 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

iOMEDICO AG

Data source: iOMEDICO AG

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.